aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Aromyx is a biotechnology company focused on quantifying and replicating human senses of smell and taste using innovative receptor technology. Their core mission is to create quantitative representations of sensory data, enabling clear, reproducible digital analysis for various applications. Aromyx aims to revolutionize industries such as food and beverage, consumer goods, and healthcare by providing unprecedented insights into sensory experiences.
Aromyx has achieved significant milestones in sensory data analysis, impacting product development and quality control across multiple sectors. Their technology has been instrumental in advancing the understanding of sensory perception, leading to improved product formulations and consumer satisfaction. Aromyx's pioneering work has attracted attention from industry leaders and investors, positioning the company as a key player in sensory biotechnology.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Biotechnology, Sensory Analysis
Technology
Biotech
Tags
SaaS
Model Types
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Aromyx founded?
Aromyx was founded in 2013.
Where is Aromyx’s headquarters located?
Aromyx’s headquarters is located in Mountain View, CA, US.
When was Aromyx’s last funding round?
Aromyx’s most recent funding round was for $10M (USD) in July 2021.
How many employees does Aromyx have?
Aromyx has 47 employees as of Feb 5, 2024.
How much has Aromyx raised to-date?
As of July 05, 2023, Aromyx has raised a total of $18.8M (USD) since Jul 20, 2021.
Add Comparison
Total Raised to Date
$18.8M
USD
Last Update Jul 20, 2021
Last Deal Details
$10M
USD
Jul 20, 2021
Series A
Total Employees Over Time
47
As of Feb 2024
Aromyx Address
319 N Bernardo Ave
Mountain View,
California
94043
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts